Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.56% | 190.48 | 1.2% | $558.09m | |
| GILD | Gilead Sciences, Inc. | -0.38% | 70.65 | 0.9% | $493.86m | |
| BIIB | Biogen Inc. | -1.56% | 314.10 | 1.3% | $441.56m | |
| CELG | Celgene Corporation | -1.04% | 69.51 | 1.2% | $414.06m | |
| ILMN | Illumina, Inc. | -0.97% | 308.15 | 3.5% | $394.41m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.62% | 336.57 | 2.6% | $277.22m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -3.73% | 163.96 | 1.9% | $261.23m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.92% | 116.24 | 2.0% | $195.24m | |
| A | Agilent Technologies, Inc. | -1.22% | 63.56 | 1.5% | $166.10m | |
| EXAS | Exact Sciences Corporation | -2.01% | 68.02 | 25.3% | $146.66m | |
| LGND | Ligand Pharmaceuticals Incorporated | -0.28% | 148.01 | 23.3% | $143.20m | |
| SRPT | Sarepta Therapeutics, Inc. | -4.88% | 111.07 | 16.4% | $127.06m | |
| ECYT | Endocyte, Inc. | -0.11% | 23.56 | 2.0% | $120.16m | |
| INCY | Incyte Corporation | -0.11% | 63.66 | 2.5% | $112.27m | |
| NKTR | Nektar Therapeutics | 1.77% | 38.01 | 5.6% | $107.73m |
Company Profile
Amicus Therapeutics, Inc. is a biotechnology company, which is engaged in the discovery, development and commercialization of novel treatments for patients living with rare and orphan diseases. Its product include migalastat HCl, which is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy for fabry disease. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ.